$8.56-0.58%
2026-10-07 close · prelimLyell Immunopharma's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$372M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Lyell Immunopharma's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$372M.